In last trading session, Tenaya Therapeutics Inc (NASDAQ:TNYA) saw 0.45 million shares changing hands with its beta currently measuring 2.44. Company’s recent per share price level of $2.89 trading at -$0.11 or -3.67% at ring of the bell on the day assigns it a market valuation of $226.92M. That closing price of TNYA’s stock is at a discount of -142.56% from its 52-week high price of $7.01 and is indicating a premium of 42.56% from its 52-week low price of $1.66. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.39 million shares which gives us an average trading volume of 389.38K if we extend that period to 3-months.
For Tenaya Therapeutics Inc (TNYA), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.37 in the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Tenaya Therapeutics Inc (NASDAQ:TNYA) trade information
Upright in the red during last session for losing -3.67%, in the last five days TNYA remained trading in the green while hitting it’s week-highest on Tuesday, 08/13/24 when the stock touched $2.89 price level, adding 7.37% to its value on the day. Tenaya Therapeutics Inc’s shares saw a change of -10.80% in year-to-date performance and have moved 9.06% in past 5-day. Tenaya Therapeutics Inc (NASDAQ:TNYA) showed a performance of -14.50% in past 30-days. Number of shares sold short was 4.43 million shares which calculate 13.71 days to cover the short interests.
Tenaya Therapeutics Inc (TNYA) estimates and forecasts
Statistics highlight that Tenaya Therapeutics Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company lost -50.00% of value to its shares in past 6 months, showing an annual growth rate of 9.52% while that of industry is 17.60. Apart from that, the company came raising its revenue forecast for fiscal year 2024.
And 5 analysts are in estimates of company making revenue of 1M in the next quarter.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -27.43% during past 5 years.
Tenaya Therapeutics Inc (NASDAQ:TNYA)’s Major holders
Insiders are in possession of 1.11% of company’s total shares while institution are holding 72.99 percent of that, with stock having share float percentage of 73.81%. Investors also watch the number of corporate investors in a company very closely, which is 72.99% institutions for Tenaya Therapeutics Inc that are currently holding shares of the company. COLUMN GROUP LLC is the top institutional holder at TNYA for having 9.4 million shares of worth $49.16 million. And as of 2024-03-31, it was holding 12.7399 of the company’s outstanding shares.
The second largest institutional holder is CASDIN CAPITAL, LLC, which was holding about 6.73 million shares on 2024-03-31. The number of shares represents firm’s hold over 9.125 of outstanding shares, having a total worth of $35.21 million.
On the other hand, Price (T.Rowe) New Horizons Fund and Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Mar 31, 2024 , the former fund manager was holding 2.58 shares of worth $7.45 million or 3.27% of the total outstanding shares. The later fund manager was in possession of 1.82 shares on Mar 31, 2024 , making its stake of worth around $5.27 million in the company or a holder of 2.31% of company’s stock.
